LOS ANGELES, Jan. 31, 2019 /PRNewswire/ -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, announced the nomination and acceptance of Timothy Donahue to Trethera's Board...
from PR Newswire: https://prn.to/2HH5crJ
No comments:
Post a Comment